Generation Historical Financial Ratios

GBIO Stock  USD 1.16  0.03  2.52%   
Generation Bio is recently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.55 or Days Sales Outstanding of 280 will help investors to properly organize and evaluate Generation Bio financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Generation Financial Ratios Analysis

Generation BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Generation Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Generation financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Generation Bio history.

Generation Bio Financial Ratios Chart

At this time, Generation Bio's Graham Net Net is very stable compared to the past year. As of the 17th of December 2024, Price Book Value Ratio is likely to grow to 0.55, while Book Value Per Share is likely to drop 2.72.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Generation Bio stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Generation Bio sales, a figure that is much harder to manipulate than other Generation Bio Co multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Net Debt To E B I T D A

A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).
Most ratios from Generation Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Generation Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
At this time, Generation Bio's Graham Net Net is very stable compared to the past year. As of the 17th of December 2024, Price Book Value Ratio is likely to grow to 0.55, while Book Value Per Share is likely to drop 2.72.
 2023 2024 (projected)
Graham Number11.811.64
Receivables Turnover1.281.35

Generation Bio fundamentals Correlations

-0.871.0-0.80.7-0.010.79-0.871.00.030.91-0.460.410.86-0.630.741.0-0.29-0.590.280.31-0.750.850.380.9-0.6
-0.87-0.870.95-0.78-0.25-0.981.0-0.87-0.21-0.970.49-0.75-0.990.7-0.8-0.870.650.87-0.320.210.91-0.98-0.22-0.970.88
1.0-0.87-0.80.7-0.010.79-0.871.00.030.91-0.460.410.86-0.630.741.0-0.29-0.590.280.31-0.750.850.380.9-0.6
-0.80.95-0.8-0.54-0.51-0.910.95-0.8-0.48-0.860.25-0.84-0.90.48-0.6-0.80.80.73-0.40.250.75-0.88-0.02-0.860.76
0.7-0.780.7-0.54-0.310.82-0.780.7-0.370.88-0.780.340.85-0.850.950.7-0.13-0.880.03-0.09-0.940.850.550.88-0.84
-0.01-0.25-0.01-0.51-0.310.21-0.25-0.010.980.030.550.740.130.33-0.27-0.01-0.82-0.070.16-0.510.030.14-0.630.04-0.12
0.79-0.980.79-0.910.820.21-0.980.790.140.96-0.530.750.99-0.720.850.79-0.65-0.940.33-0.33-0.950.970.220.96-0.94
-0.871.0-0.870.95-0.78-0.25-0.98-0.87-0.21-0.970.49-0.75-0.990.7-0.8-0.870.650.87-0.320.210.91-0.98-0.22-0.970.88
1.0-0.871.0-0.80.7-0.010.79-0.870.030.91-0.460.410.86-0.630.741.0-0.29-0.590.280.31-0.750.850.380.9-0.6
0.03-0.210.03-0.48-0.370.980.14-0.210.030.00.60.680.070.38-0.340.03-0.740.050.13-0.340.120.1-0.620.00.0
0.91-0.970.91-0.860.880.030.96-0.970.910.0-0.620.60.99-0.790.880.91-0.46-0.860.24-0.06-0.940.980.381.0-0.86
-0.460.49-0.460.25-0.780.55-0.530.49-0.460.6-0.62-0.09-0.590.91-0.67-0.46-0.040.590.16-0.040.64-0.6-0.79-0.620.53
0.41-0.750.41-0.840.340.740.75-0.750.410.680.6-0.090.68-0.370.310.41-0.93-0.640.08-0.59-0.560.72-0.270.61-0.65
0.86-0.990.86-0.90.850.130.99-0.990.860.070.99-0.590.68-0.770.870.86-0.56-0.90.29-0.19-0.950.990.320.99-0.9
-0.630.7-0.630.48-0.850.33-0.720.7-0.630.38-0.790.91-0.37-0.77-0.73-0.630.170.720.170.010.76-0.8-0.52-0.790.66
0.74-0.80.74-0.60.95-0.270.85-0.80.74-0.340.88-0.670.310.87-0.730.74-0.19-0.90.34-0.12-0.960.830.50.89-0.89
1.0-0.871.0-0.80.7-0.010.79-0.871.00.030.91-0.460.410.86-0.630.74-0.29-0.590.280.31-0.750.850.380.9-0.6
-0.290.65-0.290.8-0.13-0.82-0.650.65-0.29-0.74-0.46-0.04-0.93-0.560.17-0.19-0.290.53-0.340.650.42-0.560.35-0.470.57
-0.590.87-0.590.73-0.88-0.07-0.940.87-0.590.05-0.860.59-0.64-0.90.72-0.9-0.590.53-0.270.50.97-0.88-0.26-0.870.99
0.28-0.320.28-0.40.030.160.33-0.320.280.130.240.160.080.290.170.340.28-0.34-0.27-0.18-0.280.15-0.080.24-0.37
0.310.210.310.25-0.09-0.51-0.330.210.31-0.34-0.06-0.04-0.59-0.190.01-0.120.310.650.5-0.180.28-0.170.35-0.080.51
-0.750.91-0.750.75-0.940.03-0.950.91-0.750.12-0.940.64-0.56-0.950.76-0.96-0.750.420.97-0.280.28-0.93-0.37-0.950.97
0.85-0.980.85-0.880.850.140.97-0.980.850.10.98-0.60.720.99-0.80.830.85-0.56-0.880.15-0.17-0.930.30.99-0.87
0.38-0.220.38-0.020.55-0.630.22-0.220.38-0.620.38-0.79-0.270.32-0.520.50.380.35-0.26-0.080.35-0.370.30.37-0.22
0.9-0.970.9-0.860.880.040.96-0.970.90.01.0-0.620.610.99-0.790.890.9-0.47-0.870.24-0.08-0.950.990.37-0.87
-0.60.88-0.60.76-0.84-0.12-0.940.88-0.60.0-0.860.53-0.65-0.90.66-0.89-0.60.570.99-0.370.510.97-0.87-0.22-0.87
Click cells to compare fundamentals

Generation Bio Account Relationship Matchups

Generation Bio fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio(11.57)2.881.040.810.520.55
Book Value Per Share(2.13)9.836.784.863.152.72
Free Cash Flow Yield(0.0529)(0.0979)(0.25)(0.49)(0.57)(0.54)
Operating Cash Flow Per Share(0.87)(2.57)(1.63)(1.76)(0.82)(0.86)
Capex To Depreciation10.721.611.311.721.411.34
Pb Ratio(11.57)2.881.040.810.520.55
Free Cash Flow Per Share(1.31)(2.78)(1.74)(1.91)(0.93)(0.98)
Roic0.62(0.29)(0.3)(0.47)(0.65)(0.62)
Net Income Per Share(1.31)(2.81)(2.04)(2.27)(1.96)(2.06)
Cash Per Share0.339.626.664.84.13.91
Pocfratio(28.28)(11.02)(4.34)(2.23)(2.02)(2.12)
Capex To Operating Cash Flow(0.5)(0.0787)(0.0649)(0.0859)(0.14)(0.15)
Pfcf Ratio(18.91)(10.21)(4.08)(2.05)(1.77)(1.86)
Income Quality0.660.870.770.750.420.78
Roe0.61(0.29)(0.3)(0.47)(0.62)(0.59)
Ev To Operating Cash Flow(27.91)(10.12)(1.14)(2.12)(2.61)(2.74)
Pe Ratio(18.91)(10.1)(3.48)(1.73)(0.84)(0.88)
Ev To Free Cash Flow(18.66)(9.38)(1.07)(1.95)(2.29)(2.41)
Earnings Yield(0.0529)(0.099)(0.29)(0.58)(1.19)(1.13)
Net Debt To E B I T D A0.250.812.570.0843(0.24)(0.22)
Current Ratio1.9823.8620.1614.996.8310.61
Tangible Book Value Per Share(2.13)9.836.784.863.152.72
Graham Number7.9224.9217.6315.7711.811.64
Shareholders Equity Per Share(2.13)9.836.784.863.152.72
Graham Net Net(2.71)8.674.983.191.481.74
Enterprise Value Over E B I T D A(18.63)(9.14)(0.91)(1.59)(1.03)(1.09)
Price Earnings Ratio(18.91)(10.1)(3.48)(1.73)(0.84)(0.88)
Price Book Value Ratio(11.57)2.881.040.810.520.55
Price To Operating Cash Flows Ratio(28.28)(11.02)(4.34)(2.23)(2.02)(2.12)
Price To Free Cash Flows Ratio(18.91)(10.21)(4.08)(2.05)(1.77)(1.86)
Ebt Per Ebit0.980.991.00.970.911.07
Effective Tax Rate0.01610.050.03760.03320.02990.0152

Pair Trading with Generation Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Generation Stock

  0.94VALN Valneva SE ADRPairCorr
  0.93ERNA Eterna TherapeuticsPairCorr

Moving against Generation Stock

  0.84BMY Bristol Myers SquibbPairCorr
  0.79DYAI Dyadic InternationalPairCorr
  0.78ESPR Esperion TherapeuticsPairCorr
  0.65GILD Gilead SciencesPairCorr
  0.4DNA Ginkgo Bioworks Holdings Sell-off TrendPairCorr
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.19)
Revenue Per Share
0.28
Quarterly Revenue Growth
2.52
Return On Assets
(0.19)
Return On Equity
(0.86)
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.